Literature DB >> 26081791

Stairs instead of elevators at the workplace decreases PCSK9 levels in a healthy population.

Christel H Kamani1, Baris Gencer1, Fabrizio Montecucco1,2,3, Delphine Courvoisier4, Nicolas Vuilleumier3, Philippe Meyer1, François Mach1.   

Abstract

BACKGOUND: Regular physical activity is recommended to lower low-density lipoprotein cholesterol (LDL-C) in a healthy population. Inhibition of proprotein convertase subtilisin/kexin type 9 (PCSK9) was shown to reduce (LDL-C) levels; however, the impact of physical exercise on PCSK9 levels remains unclear.
MATERIALS AND METHODS: We used data from 67 healthy hospital employees who participated in a 6-month intervention promoting active use of stairs instead of elevators during 3 months, followed by 3 months without recommendation. We confirmed the degree of physical activity with estimated aerobic capacity (VO2 max ) and measured serum PCSK9 levels at baseline, 3 and 6 month. Using a multilevel regression model, we analysed changes of PCSK9 levels over time adjusting for age, gender, aerobic capacity, baseline LDL-C, and LDL-C and body mass index (BMI) changes.
RESULTS: At baseline, PCSK9 levels were associated with higher aerobic capacity (P-value = 0·024). At 3 months, we observed a significant decrease in mean PCSK9 levels from 403·6 to 324·3 ng/mL (P-value = 0·001), as well a significant decrease in mean LDL-C levels from 3·5 to 3·3 mM (P-value = 0·01). During this period, mean aerobic capacity (VO2 max ) increased from 37·0 to 40·4 mL/kg/min (P-value < 0·001). Physical activity was independently associated with a decrease in PCSK9 levels after adjustment for age, gender, baseline aerobic capacity, and LDL-C and BMI changes.
CONCLUSION: Daily physical activity at the work place is independently associated with a decrease in PCSK9 levels over time.
© 2015 Stichting European Society for Clinical Investigation Journal Foundation.

Entities:  

Keywords:  Biomarkers; PCSK9; lifestyle intervention; lipids; physical exercise

Mesh:

Substances:

Year:  2015        PMID: 26081791     DOI: 10.1111/eci.12480

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  5 in total

1.  Effect of Physical Activity on Plasma PCSK9 in Subjects With High Risk for Type 2 Diabetes.

Authors:  Kari Antero Mäkelä; Juhani Leppäluoto; Jari Jokelainen; Timo Jämsä; Sirkka Keinänen-Kiukaanniemi; Karl-Heinz Herzig
Journal:  Front Physiol       Date:  2019-04-30       Impact factor: 4.566

Review 2.  Coming Back to Physiology: Extra Hepatic Functions of Proprotein Convertase Subtilisin/Kexin Type 9.

Authors:  Klaus-Dieter Schlüter; Annemarie Wolf; Rolf Schreckenberg
Journal:  Front Physiol       Date:  2020-12-07       Impact factor: 4.566

3.  LDL-cholesterol and PCSK9 in patients with familial hypercholesterolemia: influence of PCSK9 variants under lipid-lowering therapy.

Authors:  Masato Hamasaki; Naoki Sakane; Kazuo Hara; Kazuhiko Kotani
Journal:  J Clin Lab Anal       Date:  2021-10-15       Impact factor: 2.352

Review 4.  Physical activity to reduce PCSK9 levels.

Authors:  Amedeo Tirandi; Fabrizio Montecucco; Luca Liberale
Journal:  Front Cardiovasc Med       Date:  2022-08-25

Review 5.  Effects of aerobic exercise on lipids and lipoproteins.

Authors:  Yating Wang; Danyan Xu
Journal:  Lipids Health Dis       Date:  2017-07-05       Impact factor: 3.876

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.